Christophe Passot

Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis

Claire Bonneau, Gilles Paintaud, Olivier Trédan et al. · European Journal of Cancer · 2018 · 95 citations

Breast Oncology, Intrathecal Administration, Breast Cancer +4

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding

David Ternant, Christophe Arnoult, Martine Pugnière et al. · The Journal of Immunology · 2015 · 68 citations

The underlying inflammatory chronic disease influences infliximab pharmacokinetics

Christophe Passot, Denis Mulleman, Théodora Bejan‐Angoulvant et al. · mAbs · 2016 · 65 citations · Full text

Inflammation, Rheumatology, Chronic Inflammatory Diseases +15

Influence of<i>FCGRT</i>gene polymorphisms on pharmacokinetics of therapeutic antibodies

Christophe Passot, Nicolas Azzopardi, Sylvaine Renault et al. · mAbs · 2013 · 63 citations · Full text

A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers

Frédéric Dumont, Christophe Passot, Jean‐Luc Raoul et al. · European Journal of Cancer · 2020 · 46 citations

Surgical Oncology, Gastrointestinal Tract Cancers, Gastrointestinal Oncology +7